The widely accepted mechanism of TTP involves the deficiency of congenital and/or antibodies to immune-mediated a disintegrin and metalloprotease with a thrombospondin type I motif, member 13 (ADAMTS13) [1,2]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.